Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL820497 | 1.00 | AURKA (0.32) | AURKAMTNR1ANTRK1HCRTR1HCRTR2 | |
| SCHEMBL13787025 | 1.00 | AURKA (0.32) | AURKAMTNR1ANTRK1HCRTR1HCRTR2 | |
| SCHEMBL820499 | 0.91 | AURKA (0.33) | AURKAMTNR1ANTRK1 | |
| SCHEMBL820496 | 0.89 | SSTR3 (0.35) | MTNR1AHCRTR1HCRTR2 | |
| SCHEMBL818314 | 0.87 | HCRTR1 (0.31) | MTNR1AHCRTR1HCRTR2MCL1 | |
| SCHEMBL820181 | 0.84 | NTRK1 (0.35) | AURKAMTNR1ANTRK1 | |
| SCHEMBL13787004 | 0.81 | — | — | |
| SCHEMBL820465 | 0.80 | MTNR1A (0.39) | AURKAMTNR1ANTRK1HCRTR1HCRTR2 | |
| SCHEMBL818673 | 0.80 | MTNR1A (0.39) | AURKAMTNR1ANTRK1HCRTR1HCRTR2 | |
| SCHEMBL823087 | 0.76 | XIAP (0.36) | AURKAMTNR1ANTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110288116-A1 | IAP INHIBITORS | TETRALOGIC PHARMACEUITCAL CORPORATION (US) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288116-A1 | IAP INHIBITORS | XIAP, BIRC5, BIRC7 | AURKA 1959/4885MTNR1A 4534/4885NTRK1 4793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.